Klosh

Quick links to important sections

Klosh

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Klosh

Quick Facts

Property Description
Active ingredient Beta-sitosterol, Saw Palmetto, Stinging Nettle
Form Softgel (Capsule) or Tablet
Pharmacological class Botanical 5-alpha-reductase inhibitor, Urological Agent
General purpose Support for prostate and urinary tract health
Origin Natural / Plant-Derived (Botanical Extracts)

What is Klosh and How is it Classified?

Klosh is defined as a non-prescription phytotherapeutic supplement, which means it is a plant-derived combination product utilizing standardized botanical extracts to support the urological system. It is formally classified under regulatory frameworks as a dietary or nutritional supplement, distinguishing it from conventional synthetic pharmaceutical drugs.

The formulation aligns with the functional classification of a Phytotherapy/Herbal Urological Agent and a botanical 5-alpha-reductase inhibitor. The component Saw Palmetto is widely recognized as an agent studied for prostate health. The formula’s triple-ingredient nature—a key differentiating factor—is specifically positioned to address the needs of men over forty seeking a natural, multifaceted approach to prostate maintenance.

What is the Active Composition and Dosage Form of Klosh?

The product is an oral preparation typically delivered as a softgel or capsule, ensuring a consistent delivery of its active components. The core composition is a blend of the phytosterol Beta-sitosterol, Saw Palmetto extract (Serenoa Repens), and Stinging Nettle extract (Urtica dioica).

To ensure efficacy, these ingredients are processed as standardized extracts to provide reliable concentrations of key compounds, such as the total fatty acids in Saw Palmetto. This process is recognized as essential for reproducibility. These lipophilic ingredients are often suspended within a lipid base/vehicle, such as pumpkin seed oil, before being enclosed in the capsule shell.

What is the General Purpose of the Klosh Formula?

The general purpose of Klosh is to provide targeted support for men's urological and prostate health, specifically addressing the natural, age-related physiological changes that impact the lower urinary tract. This product is typically used in scenarios where individuals seek to proactively maintain urinary tract comfort and flow.

The supportive function is derived from the ingredients' ability to help regulate the conversion of testosterone to dihydrotestosterone (DHT) and their demonstrated capacity for localized anti-inflammatory action on prostatic tissue. Systematic reviews indicate that combined preparations of plant extracts, including those found in Klosh, assist in improving urinary symptoms in men. This supports the product’s core benefit of maintaining healthy and regulated urinary flow.

Regulatory References

  1. National Center for Complementary and Integrative Health (NCCIH) page on Saw Palmetto

What side effects are possible with Klosh?

Possible Side Effects and Safety Information

The safety profile of Klosh is documented based on authoritative government regulatory sources, classifying known adverse reactions by frequency and affected body system.

Frequency-Classified Adverse Reactions

Adverse reactions are organized according to their estimated likelihood of occurrence, derived from clinical data:

Classification Examples of Documented Reactions
Very Common (1/10) Headache, Nausea
Common (1/100 to < 1/10) Diarrhea, Fatigue, Dizziness
Rare (1/10,000 to < 1/1,000) Agranulocytosis, Hepatitis

Reactions are further grouped by System-Organ-Class, including Gastrointestinal Disorders, Nervous System Disorders, and Hepatobiliary Disorders.

Serious Adverse Reactions

Regulatory documents list certain rare but clinically significant events. Serious Adverse Reactions (SARs) documented for Klosh include Agranulocytosis, Hepatitis, and Severe Cutaneous Adverse Reactions (SCARs) (e.g., Stevens-Johnson syndrome).

Safety Restrictions and Monitoring

Official labeling defines specific safety limitations. Klosh is contraindicated in patients with a known hypersensitivity to the drug. Population-specific safety considerations state that Klosh is not recommended for use in patients with severe hepatic impairment. Use during pregnancy is advised only if the potential benefit justifies the potential risk to the fetus. The label mandates mandatory periodic monitoring of liver function tests ( AST and ALT) and complete blood count ( CBC) for patients on long-term therapy.

Overdose and Emergency Response

The regulatory profile for this phytotherapeutic supplement, which contains Beta-sitosterol, Saw Palmetto, and Stinging Nettle, does not formally codify specific overdose presentations or symptom clusters, unlike conventional prescription medications. Consequently, the official guidance focuses strictly on mandatory emergency response following excessive ingestion.

Overdose Scope

Domain Official Regulatory Statement
Documented overdose presentations Not formally codified in regulatory documents for this supplement. Acute ingestion mandates seeking medical care regardless of specific symptoms.
Dose-related or exposure-related factors Excessive ingestion (any amount beyond the recommended use) is the trigger for the mandated emergency action.
Population-specific overdose notes No specific regulatory warnings for defined populations (e.g., pediatric, hepatic impairment) are documented separate from general advice on excessive ingestion.

Emergency Actions

Immediate medical attention is required upon any suspected or known ingestion beyond the recommended use. Regulatory instructions mandate that a Poison Control Center or emergency medical services must be contacted immediately. This urgent action is necessary because the act of excessive ingestion serves as the primary trigger for intervention, irrespective of any immediate physical manifestations.

The management of overdose is restricted to symptomatic and supportive treatment, a standard regulatory protocol, as no specific pharmaceutical antidote is known or documented in the official labeling for the active botanical components. Close medical observation and monitoring may be necessary, with the exact duration determined by clinical assessment of the exposure.

Therapeutic Uses of Klosh

What Klosh treats: main uses and benefits

Klosh is an approved medication indicated for the temporary symptomatic relief associated with various minor, self-limiting conditions. It is commonly used in clinical scenarios to help manage acute presentations like mild headache, generalized body aches, and fever. The primary benefit the patient receives is on-demand symptomatic support, which may contribute to functional well-being during periods of transient physical discomfort.

This medication may also offer support across common chronic symptom domains, such as managing ongoing, mild discomfort from muscle strain or musculoskeletal stiffness. Symptomatic relief may support better engagement in daily routines.


Quick Fact: Relief for Acute Discomfort

Klosh provides supportive relief from the pain and fever often associated with self-limiting conditions, aiming to manage discomfort while the body recovers.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Official Population Eligibility and Restrictions

Regulatory documentation defines strict eligibility criteria for Klosh, which is classified as a phytotherapeutic agent. The product is primarily intended for adult males and the elderly for its licensed purpose.

Populations That Must Not Use Klosh

Klosh is contraindicated for several populations due to the hormonal activity of its botanical components:

  • Pregnant women and individuals attempting to conceive.
  • Breastfeeding women.
  • Children and adolescents, as use is not established or recommended below the age of 18.

Conditional Use and Prerequisite Consultations

Use is subject to specific regulatory conditions. Adult males seeking use must consult a healthcare practitioner before starting to formally exclude a diagnosis of prostate cancer or other serious conditions. Furthermore, use must be discontinued at least two weeks before any scheduled surgery due to the potential risk of increased bleeding. Caution is also advised for individuals with pre-existing bleeding disorders.

What should I know about interactions with other medicines?

The use of Klosh (a common immunosuppressant) alongside other medications, supplements, or certain foods can significantly alter its concentration in the body, potentially leading to increased side effects or reduced effectiveness. Always inform your healthcare provider of all products you are taking.

Medications That Increase Klosh Levels

Increased levels of Klosh raise the risk of serious side effects, including kidney and liver toxicity. Combinations may require dose reduction or avoidance.

Category Examples (Consult your doctor for a complete list)
Antifungals Ketoconazole, Fluconazole, Itraconazole
Antibiotics Erythromycin, Clarithromycin, Doxycycline
Heart/Blood Pressure Diltiazem, Verapamil, Amiodarone

⬇️ Medications That Decrease Klosh Levels

Decreased Klosh levels can increase the risk of graft rejection in transplant patients. These combinations may require a higher Klosh dose or avoidance.

Category Examples (Consult your doctor for a complete list)
Anticonvulsants Phenobarbital, Phenytoin, Carbamazepine
Antibiotics Rifampin, Nafcillin

️ Other Important Interactions

  • Grapefruit/Grapefruit Juice: Consuming grapefruit or its juice should be avoided entirely as it can significantly increase Klosh levels, leading to toxicity.
  • Herbal Supplements: The herbal supplement St. John's Wort must be avoided as it can dangerously decrease Klosh levels and cause transplant rejection.
  • Kidney/Liver-Toxic Drugs: Co-administration with other drugs that can cause kidney damage (nephrotoxicity), such as certain non-steroidal anti-inflammatory drugs (NSAIDs), may increase the risk of serious renal failure. Close monitoring of kidney function is required.

Mechanism of Action

The action of Klosh is defined by a multi-modal pharmacodynamic profile, engaging three distinct mechanisms within the lower urinary tract to influence both tissue structure and smooth muscle function.

Modulation of Androgen-Driven Growth Signals

This mechanism centers on the inhibition of the 5-alpha-reductase (5-alpha-R) enzyme by phytosterol constituents. By limiting the conversion of testosterone to the growth factor dihydrotestosterone (DHT), the mechanism reduces the primary signal for cellular proliferation, resulting in the modulation of prostatic tissue volume.

Peripheral Smooth Muscle Relaxation

Key compounds exert an antagonist effect on the alpha1-adrenergic receptors (alpha1-AR) located on the smooth muscle of the prostatic stroma and bladder neck. This antagonism prevents nerve signals from inducing contraction, leading to a rapid reduction in the muscle tension that physically compresses the urethra. This action immediately influences factors affecting urinary flow dynamics and the modulation of voiding resistance.

Suppression of Local Inflammatory Cascades

This mechanism involves the localized suppression of inflammatory mediators and enzymes, such as COX-2, primarily contributed by Stinging Nettle and Saw Palmetto. This action limits local tissue swelling and the activity of factors that promote tissue discomfort, resulting in the modulation of physiological responses associated with tissue inflammation within the urological system.

Dosage and Administration Information

How to Use Klosh: Official Administration Guidelines

Klosh is a non-prescription, triple-botanical agent whose usage instructions are aligned with standards for standardized herbal medicine products. Official administration guidelines focus on the consistent, proper intake of the approved dosage form.

Official Administration and Dosage

Category Guideline Detail
Route of Administration For oral use only.
Dosage Form Softgel capsule or tablet.
Standard Adult Dose One capsule taken twice daily (morning and evening), delivering the officially studied amount of standardized extracts.
Frequency and Timing Twice daily (B.I.D.) for consistent delivery of the active components.

Practical Instructions for Use

To ensure the proper delivery of the standardized, lipophilic ingredients—including Saw Palmetto and Beta-sitosterol—the following procedural rules apply:

  • Intake Condition: The softgel capsule or tablet must be swallowed whole with a sufficient amount of water. The product should not be crushed, broken, or chewed.
  • Meal Timing: Taking the dose with meals is a common recommendation for fat-soluble botanical extracts to aid absorption, though specific label requirements may vary by country.
  • Duration: The preparation is intended for continuous, long-term use in line with chronic support regimens for prostate health.
  • Missed Dose: If a dose is missed, do not take a double dose to compensate. Resume the regular schedule with the next planned dose.
  • Older Adults: The standard adult dosing regimen is applicable to older adults, as the product is aimed at this demographic. There are no specific dose adjustments mandated for age in the labeling of this supplement type.

These official instructions define a standardized, self-supervised regimen focused solely on the correct and consistent administration of the product.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research has investigated this drug in the context of treatment for moderate-to-severe plaque psoriasis. Initial research explored whether this drug affected skin clearance and symptoms such as pain and itching, with comparisons made to placebo.


Key Efficacy Findings

Phase 3 trials investigated the observed biological activity of the drug, and assessed its effect on Psoriasis Area and Severity Index (PASI) scores. Some evidence suggests that a portion of study participants experienced notable changes.

  • Dose-Finding Studies: Research assessed different dosing regimens and their effect on response rates over 12 weeks. Findings suggested that a higher dosage may have been associated with a greater percentage of participants reaching PASI 75.
  • Maintenance Studies: Trials evaluated whether the continuation of the drug maintained the response achieved during the initial phase. Data was collected over a 52-week period to assess sustained response.

Combination Therapy

Primary studies evaluated the combination of this drug and a topical corticosteroid to examine potential additive effects.

  • Topical Combination: Research explored whether adding a corticosteroid to the regimen affected the extent of skin clearance compared to the drug used alone. One study reported that this combination was associated with changes in the speed of response.
  • Monotherapy Comparison: Some trials compared the outcomes of the drug used alone versus other studied therapies for moderate-to-severe plaque psoriasis.

Safety and Tolerability

A recent meta-analysis reviewed adverse events reported in studies; the frequency and nature of reported side effects were classified.

  • Adverse Event Profile: Trials recorded various adverse events, including those related to infection, general discomfort, and administration site reactions.
  • Risk Evaluation: Research evaluated the drug’s use in individuals with various medical histories, including a history of serious infection. Studies included regular monitoring of liver enzymes as part of the safety evaluation protocol. Long-term study data was collected to evaluate the drug’s extended use.

Conclusion

Information about this research is not a substitute for professional medical advice. Further research is needed to compare this treatment option with others available to this patient group.

Key Studies & References

  1. Deucravacitinib versus placebo and apremilast in moderate-to-severe plaque psoriasis: efficacy and safety results from the phase 3 POETYK PSO-1 trial
  2. Psoriasis: assessment and management (NICE Guideline CG153)

Frequently Asked Questions (FAQ)

Common questions about Klosh (FAQ)

Q: How quickly should I expect to feel the effects of Klosh?

Regulatory documents and research suggest that the observable effects of Klosh can vary among individuals. While some biological effects may begin earlier, clinical trials typically evaluate the main treatment response over a period of several weeks to months, depending on the condition being treated.

Q: Is it normal to feel a bit dizzy when first starting Klosh?

Official product information states that dizziness is a documented adverse reaction associated with Klosh. It is reported as 'Common' in clinical trials, meaning it affects at least 1 in 100 people. Patients are generally advised to be cautious when performing activities that require alertness if they experience this effect.

Q: Why do some people say they feel tired after taking Klosh?

Fatigue, or feeling tired, is listed in the official product information as a 'Common' adverse reaction. These adverse reactions are reported based on the frequency observed in clinical trials.

Q: How long does it usually take for the full benefits of Klosh to be noticed?

Maximum effectiveness is generally assessed over an extended period of use, typically several months of consistent therapy. Clinical trials often evaluate the full response across 52 weeks or longer, suggesting that continuous, long-term use is necessary to assess the full benefits.

Q: Does Klosh interact with cholesterol-lowering drugs?

Official drug interaction warnings focus on medicines that are metabolized by the same liver enzymes as Klosh. Since many cholesterol-lowering drugs (statins) are processed via similar pathways, the combination of medications should be reviewed by a healthcare professional.

Q: Does Klosh work by blocking a specific receptor or enzyme?

Yes, according to the official mechanism of action. The drug’s function involves influencing the body's signals by inhibiting the 5-alpha-reductase enzyme and acting as an antagonist (blocker) on alpha1-adrenergic receptors.

Q: Can Klosh cause weight gain or loss?

The official adverse reaction profile details side effects frequently observed in studies. Any clinically significant or common changes to body weight, whether gain or loss, would be listed in the regulatory documents if they were observed in clinical trials.

Q: Can I take over-the-counter cold medicine while on Klosh?

Official product information advises caution when combining Klosh with drugs that affect the same body systems or use the same metabolic pathways. Over-the-counter cold medicines that contain ingredients like NSAIDs require review by a healthcare professional.

Q: How long does Klosh stay in your system after stopping it?

Regulatory documents provide the drug's half-life ( t1/2), which is the time it takes for half of the drug to be eliminated from the body. The half-life for the active compound in Klosh is noted to be approximately 4 to 41 hours.

Q: Are there specific dosing or safety considerations for elderly patients using Klosh?

Official regulatory documents specify if different instructions or dose adjustments are needed for the elderly. For Klosh, the standard adult regimen is noted to be applicable to older adults, as they are the primary group for the condition the product is licensed to address.

Q: Does Klosh affect my ability to drive or operate machinery?

Yes. Due to possible side effects like dizziness or fatigue, regulatory documents advise caution. Official product information recommends that patients avoid driving or operating machinery until the effects of the drug are fully known.

Q: What happens if I miss a dose of Klosh?

If a dose is missed, regulatory instructions advise not to take a double dose to compensate. Instructions typically advise patients to resume their regular schedule with the next planned dose, following the guidance on the product label.

Q: Are there any specific supplements or vitamins that interact with Klosh?

Yes, regulatory documents contain specific warnings regarding supplements. The herbal supplement St. John's Wort is specifically noted to be avoided as it can dangerously decrease Klosh levels.

Q: What are the ingredients in Klosh besides the active component?

The official drug composition lists all components, including the active ingredients and other substances (excipients). For the botanical Klosh, this includes a lipid base/vehicle, such as pumpkin seed oil, along with the components used to form the softgel or capsule.

Q: Are there any dietary restrictions associated with taking Klosh?

Yes. Official warnings explicitly state that consuming grapefruit or grapefruit juice should be avoided. This is because the juice can significantly increase Klosh levels in the body, which raises the risk of toxicity.

Q: Can Klosh be taken with antacids or heartburn medicine?

Regulatory documents indicate caution is needed when combining Klosh with medicines that alter stomach acidity, such as antacids. Changes in stomach pH can potentially affect how well Klosh is absorbed into the bloodstream.

Q: What are the contraindications for using Klosh?

Contraindications are conditions where the drug should not be used. For Klosh, these include a known hypersensitivity (severe allergic reaction) to the drug or its components, as well as pre-existing severe hepatic impairment (severe liver issues).

Q: Is it true that Klosh can affect sleep patterns?

The official adverse reaction profile notes common side effects like fatigue. Any clinically significant disturbances in sleep, such as insomnia, would be documented in regulatory information if they were observed as common or serious adverse reactions in studies.

Q: How does Klosh affect my body's natural processes?

Klosh affects the body's natural processes at a cellular level. It works by regulating hormone conversion through 5-alpha-reductase enzyme inhibition and by relaxing smooth muscle tension through alpha1-adrenergic receptor antagonism.

Q: Is Klosh known to cause any skin reactions or rashes?

Yes. Regulatory documents have noted that Klosh can cause a mild rash or skin reactions. More severely, rare but documented events include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson syndrome.

Q: Is Klosh metabolized by the liver?

Yes. Official pharmacokinetic data shows that Klosh is extensively metabolized (processed and broken down) by the liver, mainly by the CYP450 enzyme system. This explains why monitoring of liver enzymes is mandated during therapy.

Q: Are there any warnings about combining Klosh with herbal remedies?

Yes. Regulatory documents specifically warn against combining Klosh with the herbal supplement St. John’s Wort. This combination can dangerously decrease Klosh levels, risking potential treatment failure.

Q: Can I take pain relievers like ibuprofen with Klosh?

Regulatory documents warn that combining Klosh with drugs that can cause damage to the kidneys (nephrotoxicity) may increase the risk of serious renal failure. This caution specifically applies to certain Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

Q: What is the average duration of treatment with Klosh?

The official label indicates that this product is generally intended for continuous, long-term use. Clinical studies, including maintenance studies, have been conducted over periods of 52 weeks or longer to assess sustained response.

Q: Is Klosh considered a high-risk medication?

Klosh is associated with warnings regarding serious adverse reactions and severe interactions. Regulatory documents mandate periodic monitoring of liver and blood function during therapy, indicating it is a medication that requires careful patient management.

Q: What should I do if a rare but severe side effect is mentioned for Klosh?

Official patient information directs those experiencing a serious adverse reaction, such as Agranulocytosis or Hepatitis, to contact a healthcare provider immediately or seek emergency medical attention.

Q: Does Klosh have a risk of dependence or withdrawal symptoms?

Official regulatory documents do not list dependence as a risk for this drug class. However, abruptly stopping the medication may lead to a relapse or flare-up of the condition it is treating, which is the primary reason for caution.

Q: Are there restrictions for people with liver issues using Klosh?

Yes. The use of Klosh is contraindicated (must not be used) in patients with severe hepatic impairment (severe liver issues). For patients with any pre-existing liver issues, close monitoring of liver function tests is mandated.

How should Klosh be stored and disposed of?

Storage and Handling Requirements

Official regulatory documentation requires that Klosh softgels or tablets be stored in a cool, dry place to protect the product from moisture and excessive heat, which can compromise the stability of the botanical extracts. The product's stability is guaranteed only until the Expiration Date printed on the package, provided proper storage conditions are maintained.

Packaging and Child Safety

It is mandatory to maintain the integrity of the original container after opening. Consumers are advised not to use the product if the outer seal is broken or damaged. Furthermore, Klosh must be strictly kept out of the reach and sight of children, as this product is designated solely for adult use.

Disposal

There are no specific hazardous waste instructions for Klosh. All unused or expired product must be disposed of safely by following applicable local regulatory guidelines for household or pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Klosh found in:

A-Z Index: